Enalare Files Additional Patent Application for Lead Compound ENA-001 - Enhancing Potential Global Exclusivity Through 2042
Press release content from Newswire. The AP news staff was not involved in its creation.
United States Morgan Wagner Trademark Office Enalare Therapeutics Inc Human Service Office Of The Biomedical Advanced Research
Source: apnews.com